http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-10251927-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb66d9373d09efad73c142762f6dfb00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00
filingDate 2002-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd0aed395d27fb818f9734bfb4ec9d89
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_234033774dc263c34ef46d6e53d65e9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40bb26af4f395aa4790c02bf46eff82a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad1576aca892a4884b7870ca6fdac732
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_994087fbb6b982973bc2988f93510c3f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d21811f6b50a0703eccf8ec269373e8a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37067ab0439f119d909082ad40126814
publicationDate 2004-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DE-10251927-A1
titleOfInvention New xanthine derivatives, their preparation and their use as pharmaceuticals
abstract The present invention relates to substituted xanthines of the general formula in which R 1 to R 4 are as defined in claim 1, their tautomers, their stereoisomers, their mixtures, their prodrugs and their salts, which have valuable pharmacological properties, in particular an inhibitory effect on the activity of the enzyme dipeptidyl peptidase-IV (DPP-IV ).
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7816364-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012135570-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10555929-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8486646-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8198232-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8030270-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2116235-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7803753-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7803754-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012170702-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011127051-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8022034-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11253508-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7833730-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8003597-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011005929-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7838254-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8101626-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012145361-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014074668-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8580526-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013055910-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11400072-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3323818-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012040279-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012145604-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012145603-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10772865-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8026074-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8883714-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2253311-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8017574-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8026212-B2
priorityDate 2002-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12093243
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419608867

Total number of triples: 63.